A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is to prove that there is no difference in the number of healthy male volunteers that will experience pyrexia (i.e. fever with body temperature of 38°C or higher) within a 24 hour period after administration of a single dose of 6mg/kg of PF-05280014 or trastuzumab sourced from the United States (trastuzumab-US). The study will also compare the safety of both drugs.
Epistemonikos ID: 25eca075df8ab4b0d78047c12effc2ff5a868084
First added on: May 11, 2024